0001567264-24-000054.txt : 20241205 0001567264-24-000054.hdr.sgml : 20241205 20241205111641 ACCESSION NUMBER: 0001567264-24-000054 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241205 DATE AS OF CHANGE: 20241205 EFFECTIVENESS DATE: 20241205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTENSITY THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001567264 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461488089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-531169 FILM NUMBER: 241528217 BUSINESS ADDRESS: STREET 1: 1 ENTERPRISE DRIVE, SUITE 430 CITY: SHELTON STATE: CT ZIP: 06484 BUSINESS PHONE: 203-221-7381 MAIL ADDRESS: STREET 1: 1 ENTERPRISE DRIVE, SUITE 430 CITY: SHELTON STATE: CT ZIP: 06484 FORMER COMPANY: FORMER CONFORMED NAME: Intensity Therapeutics, Inc. DATE OF NAME CHANGE: 20130117 D 1 primary_doc.xml X0708 D LIVE 0001567264 INTENSITY THERAPEUTICS, INC. 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 203-221-7381 DELAWARE Intensity Therapeutics, Inc. Corporation true Lewis H. Bender 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Executive Officer Director Daniel Donovan 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Director Emer Leahy 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Director Mark A. Goldberg 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Director Thomas I.H. Dubin 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Director Joseph Talamo 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT CONNECTICUT 06484 Executive Officer Biotechnology Decline to Disclose 06b false 2024-11-21 false true true false 0 A.G.P./Alliance Global Partners 8361 None None 590 Madison Avenue, 28th Floor New York NY NEW YORK 10022 All States false Brookline Capital Markets, a division of Arcadia Securities, LLC 44656 None None 600 Lexington Avenue, Floor 30 New York NY NEW YORK 10022 All States false 3649483 3649483 0 Represents the aggregate exercise price of warrants for 1,237,113 shares of common stock issued in connection with a registered direct offering of 1,237,113 shares of common stock false 1 119999 100000 $119,999.96 is for a fee of 4.0% of the gross proceeds of the sale of securities in the registered direct offering and concurrent private placement of warrants, and up to $100,000 is for the reimbursement of expenses incurred by the placement agent. 0 false INTENSITY THERAPEUTICS, INC. /s/ Joseph Talamo Joseph Talamo CFO 2024-12-05